Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
PERRIGO Co plc | Director | Ordinary Shares | 25.5K | $770K | $30.22 | May 15, 2024 | Direct |
Theravance Biopharma, Inc. | Director | Ordinary Shares | 63.6K | $549K | $8.64 | May 8, 2024 | Direct |
Theravance Biopharma, Inc. | Director | Share Option (Right to Buy) | 23.6K | May 8, 2024 | Direct | ||
PERRIGO Co plc | Director | Restricted Stock Units | 0 | May 15, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PRGO | PERRIGO Co plc | May 14, 2024 | 4 | $138K | 4 | May 16, 2024 | Director |
TBPH | Theravance Biopharma, Inc. | May 8, 2024 | 2 | $0 | 4 | May 10, 2024 | Director |
PRGO | PERRIGO Co plc | May 17, 2023 | 3 | $133K | 4 | May 19, 2023 | Director |
PRGO | PERRIGO Co plc | May 15, 2023 | 1 | $0 | 4 | May 17, 2023 | Director |
TBPH | Theravance Biopharma, Inc. | May 2, 2023 | 2 | $0 | 4 | May 4, 2023 | Director |
TBPH | Theravance Biopharma, Inc. | Nov 22, 2022 | 1 | -$105K | 4 | Nov 23, 2022 | Director |
PRGO | PERRIGO Co plc | May 17, 2022 | 4 | $132K | 4 | May 19, 2022 | Director |
TBPH | Theravance Biopharma, Inc. | Apr 26, 2022 | 2 | $0 | 4 | Apr 28, 2022 | Director |
PRGO | PERRIGO Co plc | May 17, 2021 | 1 | $0 | 4 | May 19, 2021 | Director |
PRGO | PERRIGO Co plc | May 7, 2021 | 3 | $130K | 4 | May 11, 2021 | Director |